How do small biotech companies make strategic decisions with limited resources? This episode dives deep into the art of prioritization and outsourcing to achieve success.
Join us as we speak with Mark Melville, Vice President of CMC, Biologics at Cullinan Therapeutics, a seasoned biotech scientist with years of experience in both large and small biotech companies. Mark shares his invaluable insights on navigating the complexities of bioprocess development and outsourcing.
In this episode, we explore:
- Discover the secrets to prioritizing projects for maximum impact
- Leverage outsourcing for flexibility and expertise
- Learn to build strong relationships with external vendors to ensure top-notch quality and regulatory compliance.
Connect with Mark Melville:
LinkedIn: https://www.linkedin.com/in/mark-melville-a9a43b2
Next Steps:
Wondering how to develop biologics with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment
Develop biologics better, faster, at a fraction of the cost with our Fractional CTO services. Curious? DM us at https://bruehlmann-consulting.com
Support the show
Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up, Cell Culture Innovation